Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Observational

Hemorrhagic Shock in Orthopedic Fractures

NCT07695129 · tracked via the Priya Life Science Egypt tracker
Phase
Observational
Started
2026-07-25
Last updated
2026-07-10

Condition(s) studied

Hemorrhagic ShockPelvic FracturesLong Bone Fractures

Study summary

The goal of this observational study is to learn about the incidence and predators of hemorrhagic shock in patients with Long bone and pelvic fractures .The main question it aims to answer is:

In which bone fracture the prediction and detection of hemorrhagic shock should be in consideration for emergency management in polytrauma patients

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Patients aged between 18 and 65 years * Presentation with radiologically confirmed: * Long bone fractures (femur, tibia, fibula, humerus, radius, ulna) and/or * Pelvic fractures * Presentation within 24 hours of injury Exclusion Criteria: * Penetrating trauma to the abdomen and/or the chest. * Known bleeding disorders. * Patients on anticoagulants. * Major external hemorrhage requiring immediate surgical control * Isolated minor fractures (e.g., bones of hands or feet). * Dead on arrival

Primary outcome measure(s)

  • Incidence of hemorrhagic shock — 1 hour ,2 hours , 4 hours and 6 hours
    Shock index ≥ .9 Systolic blood pressure measurement \< 90mmHg

Trial sites (1)

FacilityCityRegionStatus
Sohag University Sohag Egypt
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07695129 on ClinicalTrials.gov ↗ ← All trials in Egypt